Sobre nosotros

About us

Alcura was established in Spain in 1992, under the name CERF Catalunya, as a pharmaceutical distributor. The company took the important step towards specialisation in logistics management for clinical trials in 1999. In 2005, it joined the Alliance Healthcare group as SFH Egara and in March 2014 changed its name to ALCURA HEALTH ESPAÑA S.A.

Alcura, always striving to meet market needs, partners with healthcare companies, professionals and organisations to provide customised, innovative solutions that improve patient care and adherence to treatment.

Our international reach allows us to help research teams, pharmaceutical companies and contract research organisations (CROs) ensure proper logistics for their clinical trials in various countries. We can provide you with a variety of innovation options in the fields of research, market access and brand solutions.

One unique vendor to add value to your brand

Our centralised model allows us to adapt to your needs, from providing one service in one country, to multiple services on a global scale.

Alcura operates in seven countries in Europe: United Kingdom, France, Spain, Italy, Netherlands, Germany and Romania.

As a member of Walgreens Boots Alliance, the largest global pharma-based health and wellness company in the world, we can leverage the professional and logistics experience of all the members of the group, who are present in more than 25* countries.

Alcura, dedicados al cuidado del paciente

Our ability to integrate services from our international group to support Alcura’s core offering makes us unique.

Healthcare company services

Alcura provides innovative solutions for anyone working in healthcare R&D, designed to fit the specific needs of each client. We can help:

  • Guarantee and ensure compliance with GxP quality standards for clinical trials,

  • Optimise resources to boost trial efficiency,

All of this will ensure you get results with your drugs and meet your strategic goals.

Walgreens Boots Alliance

Alcura belongs to Alliance Healthcare, the Pharmaceutical Wholesale Division of Walgreens Boots Alliance.

Walgreens Boots Alliance (Nasdaq: WBA) is the largest global pharma-based health and wellness company in the world. 

The company was created when Walgreens and Alliance Boots merged in 2014, bringing together two market leaders with iconic brands, complementary distribution areas, shared values and trusted healthcare heritage in community chemists and pharmaceutical distribution that goes back 100 years.

Walgreens Boots Alliance is the largest global pharma-based health and wellness company in the world. The company employs over 415,000* people and is present in more than 25* countries. It is the largest retail pharmacy, health and daily living destination across the US and Europe. Including its share in other companies, Walgreens Boots Alliance is the global pharma-based health and wellness retail leader, with more than 18,500* establishments in 11* countries. The company has the largest global pharmaceutical distribution network, with more than 390* distribution centres delivering to over 230,000** chemists, doctors, healthcare centres and hospitals each year in 20* countries. Plus, it is the world’s largest purchaser of prescription drugs and other health and wellness products.

The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty brands, such as No7, Soap & Glory, Liz Earle, Botanics, Sleek MakeUP and YourGoodSkin.
At Wallgreens Boots Alliance, we are proud to be a force for good. Leveraging our decades of experience and international scope, we carry out numerous social responsibility and sustainability initiatives to help take care of people and the planet, with a positive impact on the health and wellbeing of millions of people.


More information is available at​ www.walgreensbootsalliance.com.


* As of 31 August 2018, using publicly available information from AmerisourceBergen.
** For 12 months ending 31 August 2018, using publicly available information from AmerisourceBergen.

Contact us

To speak to a member of our team call:

+34 937 360 870